BHLHE41 and nonpapillary renal cell carcinoma: An interesting possibility that is consistent with this is that in ccRCC the risk allele acts by increasing BHLHE41 expression and restricting anti-tumorigenic effects of HIF-1α at an early-stage in ccRCC development[15,18].